✕

Amrita Nallathambi, PhD

Protein Designer

✕

Ana-Maria Bratovianu, MSc

Scientist & Co-Founder

✕

Areso Ahmadsay, MSc

Admin & Operations

✕

Bryan White

Board Member & Co-Founder

✕

Chris Norn, PhD

CEO / Co-Founder / Board Member

Chris Norn co-founded Skape Bio with Nobel Prize winner David Baker to advance GPCR therapeutics with AI-designed biologics. He helped raise $9M to build and validate the company’s platform. Previously in the Baker Lab, Chris helped pioneer AI-driven protein design, contributing to breakthroughs including AI-designed enzymes, self-assembling nanoparticles, and the first de novo designed GPCR-activating biologic. His work focuses on translating computational design into practical medicines by creating precise, programmable proteins that modulate GPCR signaling, and Skape Bio is actively exploring platform partnerships with biopharma.

✕

David Baker, PhD

Board Observer & Co-Founder

✕

Dima Borisevich, PhD

Director of Data Engineering

✕

Emil Hertz, PhD

Head of Discovery

✕

Henrik Stage

Board Member & Co-Founder

✕

Jakob Staun Pallesen

Board Observer

✕

Jan Voss, PhD

Lead Pharmacologist

✕

Lance Stewart, PhD, MBA

Board Chair & Co-Founder

✕

Mads Jeppesen, PhD

Protein Designer

✕

Marina Mohr, PhD

Director of Operations & Strategy

✕

Matt Barnes, PhD

Chief Scientific Officer

Matt Barnes, PhD, is the CSO of Skape Bio, bringing over 25 years of R&D leadership in the pharmaceutical and biotech sectors. An expert in GPCRs, ion channels, and transporters, Matt most recently served as EVP and Chief Scientific Officer at Nxera Pharma UK (formerly Sosei Heptares). There, he led the expansion of UK R&D operations, successfully transitioning over 10 preclinical candidates and three clinical assets in a five-year span. Matt is a Fellow of the British Pharmacological Society and an active scientific advisor within the biotech ecosystem, recognized for driving high-value global partnerships with leading pharma and biotech companies.

✕

Paula Rivera Sánchez, MSc

Scientist & Co-Founder

✕

Pia Peceli, MSc

Research Assistant

✕

Robert Blazej

Board Observer

✕

Samuel Pine, PhD

VP of DMPK